scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...744211H |
P356 | DOI | 10.1371/JOURNAL.PONE.0044211 |
P932 | PMC publication ID | 3429428 |
P698 | PubMed publication ID | 22937163 |
P5875 | ResearchGate publication ID | 230769894 |
P50 | author | Kathryn M Hastie | Q96243727 |
Michelle A Zandonatti | Q96243728 | ||
Erica Ollmann Saphire | Q28320547 | ||
P2093 | author name string | Liam B King | |
P2860 | cites work | Excision of 3' termini by the Trex1 and TREX2 3'-->5' exonucleases. Characterization of the recombinant proteins | Q24291054 |
The human interferon- and estrogen-regulated ISG20/HEM45 gene product degrades single-stranded RNA and DNA in vitro | Q24291320 | ||
Innate immune recognition of viral infection | Q24498364 | ||
PHENIX: a comprehensive Python-based system for macromolecular structure solution | Q24654617 | ||
Processing of X-ray diffraction data collected in oscillation mode | Q26778468 | ||
Structural basis for proofreading during replication of the Escherichia coli chromosome | Q27638768 | ||
The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering | Q27643804 | ||
Structure of the dimeric exonuclease TREX1 in complex with DNA displays a proline-rich binding site for WW Domains | Q27644048 | ||
Structural basis for translation termination on the 70S ribosome | Q27651016 | ||
Cap binding and immune evasion revealed by Lassa nucleoprotein structure | Q27665958 | ||
Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression | Q27666703 | ||
Structure of DNA polymerase I Klenow fragment bound to duplex DNA | Q27732134 | ||
Features and development of Coot | Q27861079 | ||
The human TREX2 3' -> 5'-exonuclease structure suggests a mechanism for efficient nonprocessive DNA catalysis | Q28303398 | ||
Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing | Q33576672 | ||
Crystal structure of human ISG20, an interferon-induced antiviral ribonuclease | Q34365279 | ||
Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis | Q34596952 | ||
DNA binding induces active site conformational change in the human TREX2 3'-exonuclease | Q37169783 | ||
DNA substrate structural requirements for the exonuclease and polymerase activities of procaryotic and phage DNA polymerases | Q38345051 | ||
Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever | Q40799148 | ||
Differential inhibition of type I interferon induction by arenavirus nucleoproteins | Q41937252 | ||
Specificity and enzymatic mechanism of the editing exonuclease of Escherichia coli DNA polymerase III | Q44604513 | ||
Identification of a new motif required for the 3'-5' exonuclease activity of Escherichia coli DNA polymerase I (Klenow fragment): the RRRY motif is necessary for the binding of single-stranded DNA substrate and the template strand of the mismatched | Q81191858 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Lassa virus | Q1806636 |
P304 | page(s) | e44211 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Structural basis for the dsRNA specificity of the Lassa virus NP exonuclease | |
P478 | volume | 7 |
Q56909960 | Current research for a vaccine against Lassa hemorrhagic fever virus |
Q35487706 | Development of live-attenuated arenavirus vaccines based on codon deoptimization |
Q40972467 | Differential Inhibition of Macrophage Activation by Lymphocytic Choriomeningitis Virus and Pichinde Virus Is Mediated by the Z Protein N-Terminal Domain. |
Q64097889 | Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors |
Q30238887 | Immunobiology of Ebola and Lassa virus infections |
Q38886677 | In vitro and in vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions. |
Q36753696 | Influence of RNA Binding on the Structure and Dynamics of the Lassa Virus Nucleoprotein |
Q50238755 | Interactome analysis of the lymphocytic choriomeningitis virus nucleoprotein in infected cells reveals ATPase Na+/K+ transporting subunit Alpha 1 and prohibitin as host-cell factors involved in the life cycle of mammarenaviruses. |
Q59351260 | Lassa virus activates myeloid dendritic cells but suppresses their ability to stimulate T cells |
Q34552784 | Multiple origins of viral capsid proteins from cellular ancestors |
Q26863693 | Ribonuclease III mechanisms of double-stranded RNA cleavage |
Q40719136 | Sin Nombre hantavirus nucleocapsid protein exhibits a metal-dependent DNA-specific endonucleolytic activity |
Q36281193 | Structural and Functional Diversity of Nairovirus-Encoded Nucleoproteins |
Q27682730 | Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein |
Q57793768 | Structural insights into the duplex DNA processing of TREX2 |
Q107341961 | Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN |
Q110951004 | Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN |
Q27684274 | Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression |
Q27677263 | Structure of the Leanyer orthobunyavirus nucleoprotein-RNA complex reveals unique architecture for RNA encapsidation |
Q27677547 | Structures of Arenaviral Nucleoproteins with Triphosphate dsRNA Reveal a Unique Mechanism of Immune Suppression |
Q56913187 | The S Genome Segment Is Sufficient to Maintain Pathogenicity in Intra-Clade Lassa Virus Reassortants in a Guinea Pig Model |
Q30357836 | The SARS coronavirus nucleocapsid protein--forms and functions. |
Q41863924 | The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production |
Q38823264 | Vaccine platforms to control Lassa fever |
Search more.